The Traderszone Network

Published in TZ Latest News 20 August, 2015 by The TZ Newswire Staff

Novartis buys remaining rights to GSK treatment

Swiss drugmaker Novartis said on Friday it had agreed to buy all remaining rights to Ofatumumab from Britain’s GlaxoSmithKline.